|Bid||47.50 x 3200|
|Ask||47.65 x 800|
|Day's range||47.29 - 48.14|
|52-week range||36.74 - 55.64|
|Beta (3Y monthly)||1.05|
|PE ratio (TTM)||10.22|
|Earnings date||16 Apr 2019 - 22 Apr 2019|
|Forward dividend & yield||1.20 (2.84%)|
|1y target est||52.07|
When community activists, unions and local politicians thwarted Amazon’s plans for a corporate complex in Queens, New York, the victory rattled investors and financial advisers who hope to profit from the federal government’s Opportunity Zones programme. Before withdrawing, Amazon said it would not apply for generous tax breaks allowed under the scheme. Under a law passed in 2017, the US Treasury has designated more than 8,700 areas across 50 states as economically distressed, labelling them “opportunity zones”.
U.S. stocks ended a choppy session slightly lower as investors considered stronger-than-expected economic data from China and a latest batch of corporate earnings results.
(MS)’s wealth management business reported better-than-expected first-quarter results, rebounding from a rocky fourth quarter. The unit’s net revenue came in at $4.39 billion, up 6% from the fourth quarter of 2018 and flat from a year earlier. Meanwhile, pretax profit was $1.19 billion, up 18% from last year’s fourth quarter and 2% year over year.
Plunging healthcare stocks dragged Wall Street lower on Wednesday, offsetting a spate of upbeat corporate earnings and encouraging economic data from the United States and China. All three major U.S. stock indexes were down, but the S&P 500 slipped to more than a percent below its record high reached in September.
U.S. stocks headed lower on Wednesday, as a selloff in healthcare stocks extended for a second day, overshadowing a rally in chipmakers led by Qualcomm. Medical device maker Abbott Laboratories Inc fell 3.8%, despite quarterly results beating estimates. UnitedHealth Group Inc, Pfizer Inc and Merck & Co fell more than 2% and were the biggest drags on the broader S&P 500 index.
World stock markets pared earlier gains as a continued flight from healthcare shares dragged on Wall Street, overshadowing earlier upbeat economic data from China. The S&P 500 flattened as the healthcare index dived 2.1% on continued fallout from concerns about potential changes to U.S. policy. MSCI's 47-country world index barely remained in positive territory, having earlier been buoyed by better-than-expected Chinese data showing the country's economy grew 6.4% in the first quarter.
Wall Street's main indexes were trading flat on Wednesday, as a Qualcomm-led rally in chipmakers was offset by a slide in healthcare stocks for the second straight session, although quarterly earnings came in largely positive. Qualcomm Inc surged 10.3% after the company won a major victory in its legal dispute with Apple Inc that called for the iPhone to once again use Qualcomm modem chips.
Amid slump in investment banking and trading, Morgan Stanley's (MS) Q1 earnings beat estimates driven by loan growth and lower expenses.
U.S. stocks gave up early gains to trade marginally lower on Wednesday, as healthcare stocks continued a decline from the previous session, countering a rally in chipmakers led by Qualcomm and robust economic data out of China. The S&P healthcare index fell 1.7% as insurers and hospital operators dropped on ongoing concerns about potential changes to healthcare policy.
Morgan Stanley (MS), PepsiCo (PEP) and Kansas City Southern (KSU) are among those companies putting out Q1 earnings results this morning.
Morgan Stanley’s Q1 Earnings Fell 4%, Beat the Estimates(Continued from Prior Part)Valuation Morgan Stanley (MS) is trading at a forward PE ratio of 9.6x, which is ~16% lower than its five-year average PE ratio. The stock is trading at a PBV
(MS) stock gained another nearly 2% in premarket trading after the bank’s first-quarter earnings beat Wall Street expectations. Through Tuesday’s close, Morgan Stanley stock (ticker: MS) was up 18.5% this year, compared with 16% for the broader S&P 500. Morgan Stanley reported earnings of $1.39 per share, which beat Wall Street consensus estimates of $1.17.
Wall Street was set to open higher on Wednesday, as upbeat economic data from China and a jump in Qualcomm shares sparked gains in chipmakers, with sentiment also lifted by largely positive earnings reports. China's economy grew at a steady 6.4% pace in the first quarter, defying expectations for a further slowdown, adding to optimism that the economy may be starting to stabilize even as Beijing and Washington appear moving closer to a trade deal.
Morgan Stanley (MS) delivered earnings and revenue surprises of 13.68% and 2.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Morgan Stanley’s Q1 Earnings Fell 4%, Beat the EstimatesMorgan Stanley’s first-quarter results Morgan Stanley (MS) reported its first-quarter results on April 17. The company reported an EPS of $1.39, which beat the consensus estimates of $1.17
Morgan Stanley reported a 9 percent drop in quarterly earnings on Wednesday, but managed to beat analyst estimates through slight growth in its wealth management business, as well as cost cuts. Morgan Stanley gets about half its annual revenue from wealth management, which helps it ride out weak periods for trading and investment banking. "This quarter ... shows the resiliency of wealth management, which is an important indicator of the health of our business," Chief Financial Officer Jonathan Pruzan said in an interview.
Morgan Stanley’s chief executive has warned that banks could soon be revisited by the market turmoil that crushed trading profits late last year despite his bank topping quarterly earnings forecasts and reporting a robust start to April. by the market volatility in the fourth quarter when a 30 per cent drop in fixed income trading revenue helped to drag net income down 9 per cent. Mr Gorman and his team had a better story to tell on Wednesday.
Maxim Group maintained its buy rating of the company, citing expected solid growth in the first quarter and margin expansion, according to Briefing.com.
The New York-based company said it had earnings of $1.39 per share. Earnings, adjusted for pretax gains, were $1.33 per share. The results surpassed Wall Street expectations. The average estimate of four ...